{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:21:41Z","timestamp":1791084101977,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.vaccine.2011.05.045","type":"journal-article","created":{"date-parts":[[2011,6,13]],"date-time":"2011-06-13T04:46:54Z","timestamp":1307940414000},"page":"6321-6326","source":"Crossref","is-referenced-by-count":14,"title":["Disease-specific adverse events following nonlive vaccines: A paradoxical placebo effect or a nocebo phenomenon?"],"prefix":"10.1016","volume":"29","author":[{"given":"Claire","family":"Oka\u00efs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Seon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydie","family":"Buchaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Chary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Soubeyrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.05.045_bib0005","unstructured":"Background rates of adverse events following immunization. World Health Organization; 2000 (WHO\/V&B\/00.36), http:\/\/www.who.int\/vaccinesdocuments\/DocsPDF00\/www562.pdf [last accessed on 27.11.10]"},{"issue":"April (23\u201324)","key":"10.1016\/j.vaccine.2011.05.045_bib0010","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1016\/S0264-410X(00)00555-7","article-title":"A strong association between HLA-DR9 and gelatin allergy in the Japanese population","volume":"19","author":"Kumagai","year":"2001","journal-title":"Vaccine"},{"issue":"March (12)","key":"10.1016\/j.vaccine.2011.05.045_bib0015","first-page":"85","article-title":"Causality assessment of adverse events following immunization","volume":"76","author":"World Health Organization","year":"2001","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2011.05.045_bib0020","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(86)91044-5","article-title":"Frequency of true adverse reactions to measles-mumps-rubella vaccine: a double-blind placebo-controlled trial in twins","volume":"8487","author":"Peltola","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.05.045_bib0025","first-page":"235","article-title":"Safety assessment post-licensure","volume":"95","author":"Miller","year":"1998","journal-title":"Dev Biol Stand"},{"issue":"September (16)","key":"10.1016\/j.vaccine.2011.05.045_bib0030","article-title":"A potential competition bias in the detection of safety signals from spontaneous reporting databases","author":"Pariente","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2011.05.045_bib0035","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/522125","article-title":"The safety profile of varicella vaccine: a 10-year review","volume":"197","author":"Galea","year":"2008","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2011.05.045_bib0040","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1586\/14760584.1.4.461","article-title":"Hepatitis B vaccine and risk of multiple sclerosis","volume":"1","author":"DeStefano","year":"2002","journal-title":"Expert Rev Vaccines"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.05.045_bib0045","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pds.1001","article-title":"The reporting odds ratio and its advantages over the proportional reporting ratio","volume":"13","author":"Rothman","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2011.05.045_bib0050","unstructured":"Calendrier des vaccinations et recommandations vaccinales 2010 selon l\u2019avis du Haut conseil de la sant\u00e9 publique. Bulletin Epid\u00e9miologique Hebdomadaire 2010;(April (22)):14\u201315."},{"key":"10.1016\/j.vaccine.2011.05.045_bib0055","unstructured":"Weber JCP. Epidemiology of adverse reactions to nonstero\u00efdal antiinflammatory drugs 1984;1\u20137."},{"key":"10.1016\/j.vaccine.2011.05.045_bib0060","unstructured":"Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS), United States, 1991\u20132001. MMWR 2003;52(SS-1):1\u201324."},{"issue":"June (4)","key":"10.1016\/j.vaccine.2011.05.045_bib0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/pds.848","article-title":"Biases affecting the proportional reporting ratio (PPR) in spontaneous reports pharmacovigilance databases: the example of sertindole","volume":"12","author":"Moore","year":"2003","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"10.1016\/j.vaccine.2011.05.045_bib0070","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2009.1201","article-title":"Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine","volume":"302","author":"Slade","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.05.045_bib0190","series-title":"Vaccines","first-page":"17","article-title":"Section 1: general aspects of vaccination; vaccine immunology.","author":"Siegrist","year":"2008"},{"key":"10.1016\/j.vaccine.2011.05.045_bib0195","series-title":"The placebo effect: an interdisciplinary exploration.","first-page":"56","article-title":"The nocebo phenomenon: scope and foundations.","author":"Hahn","year":"1997"},{"issue":"September (5 Pt 1)","key":"10.1016\/j.vaccine.2011.05.045_bib0085","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1006\/pmed.1997.0228","article-title":"The nocebo effect: history and physiology","volume":"26","author":"Benson","year":"1997","journal-title":"Prev Med"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2011.05.045_bib0090","first-page":"2502","article-title":"When are medication side effects due to the nocebo phenomenon?","volume":"287","author":"Palmer","year":"2002","journal-title":"JAMA"},{"issue":"September (5 Pt 1)","key":"10.1016\/j.vaccine.2011.05.045_bib0095","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1006\/pmed.1997.0229","article-title":"Nocebo: the power of suggestibility","volume":"26","author":"Spiegel","year":"1997","journal-title":"Prev Med"},{"issue":"March (10)","key":"10.1016\/j.vaccine.2011.05.045_bib0100","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.vaccine.2009.12.044","article-title":"Skin reaction to vaccination already before injection","volume":"28","author":"Kantele","year":"2010","journal-title":"Vaccine"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.05.045_bib0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4161\/hv.5.5.6911","article-title":"Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial","volume":"5","author":"Beytout","year":"2009","journal-title":"Hum Vaccin"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.05.045_bib0110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/clpt.1987.142","article-title":"The consent form as a possible cause of side effects","volume":"42","author":"Myers","year":"1987","journal-title":"Clin Pharmacol Ther"},{"issue":"December","key":"10.1016\/j.vaccine.2011.05.045_bib0115","doi-asserted-by":"crossref","first-page":"b5613","DOI":"10.1136\/bmj.b5613","article-title":"Medicine and the Media. Thyroxine: anatomy of a health scare","volume":"339","author":"Faasse","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2011.05.045_bib0120","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/jama.1938.02790390024008","article-title":"Cold vaccines. An evaluation based on a controlled study","volume":"111","author":"Diehl","year":"1938","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.vaccine.2011.05.045_bib0125","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1542\/peds.106.5.1097","article-title":"Do parents understand immunizations? A national telephone survey","volume":"106","author":"Gellin","year":"2000","journal-title":"Pediatrics"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.05.045_bib0130","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1542\/peds.2005-1381","article-title":"Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV","volume":"117","author":"Dempsey","year":"2006","journal-title":"Pediatrics"},{"issue":"December (Suppl. 6)","key":"10.1016\/j.vaccine.2011.05.045_bib0135","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jadohealth.2005.09.010","article-title":"Improving adolescent health: focus on HPV vaccine acceptance","volume":"37","author":"Zimet","year":"2005","journal-title":"J Adolesc Health"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.05.045_bib0140","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1158\/1055-9965.EPI-06-0041","article-title":"Mothers\u2019 attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study","volume":"15","author":"Waller","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.05.045_bib0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-3999(01)00223-9","article-title":"Medically unexplained symptoms: an epidemiological study in seven specialities","volume":"51","author":"Nimnuan","year":"2001","journal-title":"J Psychosom Res"},{"issue":"November","key":"10.1016\/j.vaccine.2011.05.045_bib0150","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1037\/0003-066X.38.11.1161","article-title":"Adujstment to threatening events a theory of cognitive adaptation","author":"Taylor","year":"1983","journal-title":"Am Psychol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.05.045_bib0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1348\/135910704322778759","article-title":"The relationship of negative affect and perceived sensitivity to symptom reporting following vaccination","volume":"9","author":"Petrie","year":"2004","journal-title":"Br J Health Psychol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.05.045_bib0160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.arcped.2005.10.020","article-title":"Pharmacovigilance des vaccins","volume":"13","author":"Autret-Leca","year":"2006","journal-title":"Arch Pediatr"},{"issue":"2","key":"10.1016\/j.vaccine.2011.05.045_bib0165","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JRS-1991-2406","article-title":"Problems and possibilities of spontaneous adverse reactions reporting systems","author":"Kimbel","year":"1991","journal-title":"Int J risk saf med"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.05.045_bib0170","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1592\/phco.22.8.663.33201","article-title":"Torsades de pointes associated with fluoroquinolones","volume":"22","author":"Owens","year":"2002","journal-title":"Pharmacotherapy"},{"issue":"May (15\u201316)","key":"10.1016\/j.vaccine.2011.05.045_bib0175","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.vaccine.2004.01.020","article-title":"Use of vaccine surveillance data in the evaluation of safety of vaccines","volume":"22","author":"Postila","year":"2004","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2011.05.045_bib0180","first-page":"S49","article-title":"Statistical assessment of the association between vaccination and rare adverse events post-licensure","volume":"20","author":"Andrews","year":"2002","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2011.05.045_bib0185","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/INF.0b013e318149dfea","article-title":"Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions","volume":"26","author":"Siegrist","year":"2007","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11007651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11007651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T02:56:31Z","timestamp":1592621791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11007651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":37,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0264410X11007651"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.05.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}